In addition to the cell reprogramming strategies highlighted above, other groups are working to restore insulin-producing β cells by immunomodulation approaches to suppress the autoimmune attack characteristic of type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.